- Patients of any age may be considered as a candidate for corneal crosslinking to treat keratoconus.
- Patients 8 years old and over can have very good results with this treatment.
- Making the diagnosis as early as possible is important, and typically requires corneal topography or tomography
Reviewed by William B. Trattler, MD
Corneal crosslinking (CXL) has become a widely accepted treatment for patients with keratoconus in all age groups. The procedure has been shown to stabilize the corneal shape, and many patients can experience improvement in corneal shape following crosslinking.
One challenge is determining when a patient should undergo the CXL procedure.
While the rate of progression in adults is variable, research has shown that progression of keratoconus occurs more rapidly in children and young adults. With this in mind, clinicians need to help patients decide when to undergo the CXL procedure.
For children, the evidence suggests that early treatment is in their best interest, as this can prevent the condition from rapidly progressing.
William B. Trattler, MD, a cornea specialist at the Center for Excellence in Healthcare, Miami, believes that patients of any age can be treated with CXL, and that patients age 8 and over can do very well with the treatment.
Dr. Trattler pointed out that the rate of progression in children can be surprisingly fast.
William B. Trattler, MD
Dr. Trattler is a speaker for Oculus, a speaker and consultant for Avedro, and has a fi nancial interest in CXLO and Avedro.